BURLINGTON, N.C.--(BUSINESS WIRE)--Jan. 9, 2009--Laboratory Corporation of America(R) Holdings (LabCorp(R))
(NYSE: LH) today announced that David P. King, Chief Executive Officer,
is scheduled to speak at the 27th Annual J.P. Morgan
Healthcare Conference in San Francisco, CA. LabCorp's presentation is
planned for Wednesday, January 14, 2009 at 10:30 a.m. (Pacific Time).
A live audio webcast of the presentation will be available via the
Company Web site at www.labcorp.com
and archived for replay.
About LabCorp(R)
Laboratory Corporation of America(R) Holdings, a S&P 500
company, is a pioneer in commercializing new diagnostic technologies and
the first in its industry to embrace genomic testing. With annual
revenues of $4.1 billion in 2007, over 26,000 employees nationwide, and
more than 220,000 clients, LabCorp offers clinical assays ranging from
routine blood analyses to HIV and genomic testing. LabCorp combines its
expertise in innovative clinical testing technology with its Centers of
Excellence: The Center for Molecular Biology and Pathology, National
Genetics Institute, Inc., ViroMed Laboratories, Inc., The Center for
Esoteric Testing, Litholink Corporation, DIANON Systems, Inc., US
LABS, and Esoterix and its Colorado Coagulation, Endocrine Sciences, and
Cytometry Associates laboratories. LabCorp conducts clinical trial
testing through its Esoterix Clinical Trials Services division. LabCorp
clients include physicians, government agencies, managed care
organizations, hospitals, clinical labs, and pharmaceutical companies.
To learn more about our organization, visit our Web site at: www.labcorp.com.
Each of the above forward-looking statements is subject to change
based on various important factors, including without limitation,
competitive actions in the marketplace and adverse actions of
governmental and other third-party payors. Actual results could
differ materially from those suggested by these forward-looking
statements. Further information on potential factors that could affect
LabCorp's financial results is included in the Company's Form 10-K for
the year ended December 31, 2007, and subsequent SEC filings.
CONTACT: LabCorp(R)
Investor/Media Contact:
Bill Bonello, 336-436-7732
Company Information: www.labcorp.com
Source: Laboratory Corporation of America(R) Holdings
